Brind.

Regencell Bioscience Holdings Limited has been handling investor rights since May 28, 2026.

4 reports, 4 independent Updated Jun 16

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 4
Developments: 3
Repetition: 25%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Regencell Bioscience Holdings Limited has been handling investor rights since May 28, 2026.

Who's involved

What this event is mainly about

Nasdaq New York City

How it developed

Newest first. Tap a step to see who reported it.

Jun 16Regencell Bioscience Holdings Limited listed on the stock exchange.1 source
- pr-inside.com
Jun 7Regencell Bioscience Holdings Limited is handling class action inquiries and is listed on the electronic stock exchange (Nasdaq).1 source
- wallstreet-online.de
May 28The company is managing investor rights, with Rosen Law Firm involved.1 source
- prnewswire.com

Keep exploring

The entities involved

Nasdaq
American fully electronic stock exchange
- Nasdaq is a brand that utilizes services provided by Lumen Technologies.05:34
- Cantor Fitzgerald restated an overweight rating for MoonLake Immunotherapeutics, which trades on Nasdaq, with data provided by MarketBeat.04:27
New York City
most populous city in the United States
- A tax rollout in New York City is currently being challenged in court.04:35
- The war with Iran has begun, causing cost increases, while a global waste crisis affects urban centers.04:13

Coverage

Newest first; wire copies grouped